Horizon Therapeutics Public Ltd Co

Carmignac Gestion

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/29/2023

Shares

68,347

Value ($000)

7,907

Weight

0.1%

2023 Q2 - 2023 Q3 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/29/2023	7,907	0.1%	68,347	9/30/2023
2023 Q2	8/11/2023	3,839	0.1%	37,325	6/30/2023